Browse by Track

12-058 - Analysis and implementation of patient-specific insulin glargine syringes in the inpatient setting

12-147 - Analysis of Controlled Substance Policy and Procedure at a Community Hospital and Comparison to Best Practice Guidelines

9-187 - Assessing the financial feasibility of implementing clinical services at an independent pharmacy

12-301 - Assessing the volume and rationale of telephone calls from hospital-based health-care providers to the hospital pharmacy: A quality improvement initiative

10-192 - Assessment of Burnout within a Health-System Pharmacy Department

13-344 - Automated Dispensing Cabinet optimization: medication utilization review to reduce costs and optimize inventory

13-181 - Best practice direct oral anticoagulation process for early-directed deep vein thrombosis therapy to reduce admissions in a large community health care system

13-101 - Booster breaks: the effect of pharmacy department work breaks on employee perspectives of coworker relationships

12-098 - Comprehensive evaluation of USP 797 and 800 compliance after implementation of an IV workflow management system at an acute care teaching hospital

11-377 - Cost saving opportunities for a non-profit community hospital to mitigate the effects of losing 340b

13-388 - Cost savings associated with potential monoclonal antibody dose rounding at a large community teaching hospital

11-076 - Creating a proposal to implement a specialty pharmacy within in a health system

12-202 - Design, implementation, and assessment of an adverse event monitoring program within a self-funded prescription drug plan

12-154 - Development and implementation of a statewide drug shortage network

13-031 - Development of a visual dashboard for a specialty pharmacy

12-267 - Effectiveness of injectable opioid preservation plan implemented in a major New York Academic Medical Center

10-024 - Evaluating antibiotic selection for physician compliance with urinary tract infection electronic medical record (EMR) care pathways in a community hospital

13-345 - Evaluation and improvement of processes related to intravenous product waste across a healthcare system

12-030 - Evaluation of an oupatient-based, parmacist-led meds to beds program at a tertiary medical center in Los Angeles and a roadmap for expansion

11-130 - Evaluation of burnout among hospital and health-system pharmacists in North Carolina

12-416 - Financial impact of converting patients from warfarin to a direct oral anticoagulant (DOAC) at a rural federally qualified health center pharmacy

9-298 - High-risk fall medication administration in relation to time of fall event in an inpatient hospital setting

10-188 - Impact of 340B drug pricing on formulary decision making within a mixed-model health-system

9-214 - Impact of pharmacy resident and pharmacy students on medication therapy management completion rate and reimbursement in an independent long-term care pharmacy serving assisted living facilities

12-001 - Impact of Pharmacy-Led Medication Histories on Patient Outcomes

11-335 - Implementation and cost savings analysis of an ambulatory pharmacy and therapeutics (P&T) committee with a standardized formulary in a rural health system

10-430 - Implementation of a medication tracking tool to measure loss and waste in patient units of a community hospital

13-033 - Implementing pharmacy-prepared unit-dose packaging of ophthalmic solutions for perioperative use across a health-system

13-176 - Leveraging auto-verification to optimize pharmacist clinical activities

13-343 - Medication use evaluation of rifaximin in a community hospital system

13-149 - Patient counseling on high-risk medications to improve hospital consumer assessment of healthcare providers and systems (HCAHPS) scores and reduce hospital readmission rates

10-100 - Pharmacy impact on narcotic overrides in a community hospital emergency department

12-297 - Pharmacy Resident Led Multifocal Controlled Substances Diversion Prevention Program

10-414 - Quantification of the financial impact caused by missing medications at UPMC Hamot

10-087 - Retrospective evaluation of the cost and outcomes associated with appropriate and inappropriate antibiotic use in patients with asymptomatic bacteriuria in a community hospital

9-264 - Standardizing workflow between four retail pharmacies at a Federally Qualified Health Center in Maine

13-254 - The clinical impact of pharmacist intervention on prior authorization success rate at a University Call Center: a retrospective study

10-187 - The Impact of Patient Financial Advocates on the Satisfaction and Affordability of Specialty Infusion Therapies

10-219 - The implementation of safe workplace practices to insure compliance with USP General Chapter within a large healthcare system: Educating staff, assessing knowledge and compliance

11-302 - Transitioning to a Decentralized Pharmacy Practice Model in a Tertiary Hospital

10-323 - Use of the Delphi method in the development of a penicillin skin test protocol at a community hospital

9-119 - A retrospective cohort describing adherence rates to cardiovascular risk reduction guidelines in a single HIV clinic with an embedded pharmacist clinician providing metabolic disease management

12-342 - Adherence to updated metformin dosing recommendations in a patient-centered medical home: a comparison of provider-pharmacist team vs. provider only approaches

11-355 - Ambulatory antimicrobial stewardship for urinary tract infections: a pharmacist implementation study

12-364 - An evaluation of patient factors that may impact hemoglobin A1c lowering in pharmacist-run collaborative drug therapy management clinics for type 2 diabetes

12-146 - Analysis of services provided to geriatric home-bound patients enrolled in a program for primary care services in the home

11-217 - Analyzing the hemoglobin A1C lowering effects of glucagon-like peptide-1 agonists in a population of West Virginia Medicaid patients

10-442 - Anticoagulation control of vitamin-K antagonist in pharmacist-led clinic versus physician-led clinic

10-094 - Assessing Barriers to Medication Adherence Among Residents of Jefferson County, Alabama

10-113 - Assessing medication-related problems and their association with various patient, system, and clinical factors

11-400 - Assessing pharmacist full time equivalents (FTE) for patient care demand in a team based primary care setting

9-243 - Assessing the effect of continuous glucose monitoring (CGM) on medication adherence and glycemic control in patients with type 2 diabetes

11-045 - Assessing the impact of pharmacist-led transition of care services in a primary health care center

10-277 - Assessing the impact of translated prescription label directions for Nepalese refugee patients at a community pharmacy

9-107 - Assessing the prevalence of diabetic retinopathy in well-controlled type 2 diabetes mellitus patients on fibrate therapy

10-112 - Assessment of a newly initiated transitions of care clinic at an academic health center

10-068 - Assessment of the ability of a gamified web-based application to identify opportunities for healthcare intervention in an ambulatory care pharmacy clinic setting

9-057 - Assessment of the economic and clinical impact of an ambulatory care pharmacist position in an outpatient physician office

9-272 - Automated referral to an ambulatory care pharmacist for patients recently hospitalized with a chronic obstructive pulmonary disease exacerbation: impact on 30-day hospital readmissions

9-289 - Clinical outcomes of antibiotics use in patients with uncomplicated adult acute bronchitis

13-354 - Collecting social determinants of health data and the link to cardiovascular disease risk and intervention: the PRAPARE tool

9-436 - Community pharmacists' role in naloxone distribution during the post-operative period: a retrospective, single center, observational study

12-164 - Comparing predictors of hospital readmission for high and highest risk patients

9-049 - Comparison of glucagon-like peptide-1 receptor agonists versus insulin in combination with oral antidiabetics in patients with type 2 diabetes mellitus at an ambulatory care facility

9-240 - Comparison of risk factors for vitamin D deficiency in patients with and without sickle cell disease at an urban ambulatory care clinic

12-108 - Creation, Implementation, and Evaluation of Pharmacist-led Medicare Part D Open Enrollment Events

10-144 - Deployment of clinical pharmacy services in a primary care physician group

12-004 - De-prescribing: outcomes of a pharmacist-driven protocol for tapering benzodiazepines

11-361 - Developing a pharmacy practice care model for managing medication therapy associated with endocrinology

11-362 - Developing a pharmacy practice care model for proprotein convertase subtilsin-kexin type 9 (PCSK9) inhibitors

13-411 - Development and implementation of an orientation program and longitudinal ambulatory care rotation for pharmacy residents

12-015 - Digital medicines in chronic care management: using innovative technology to improve health outcomes in high-risk patients

9-114 - Effect of a multidisciplinary team on clinical outcomes and medication burden in rural New Mexico

12-191 - Effect of a pharmacist-led interdisciplinary dietary sodium intervention on blood pressure, sodium knowledge, and self-efficacy in patients with Stage 3 and 4 chronic kidney disease

9-210 - Effect of a reporting system in managing appropriate use of direct-acting oral anticoagulants (DOACs) in the outpatient setting

11-075 - Effectiveness of ambulatory care pharmacy management and interventions of a regional faith-based health care system

12-339 - Effectiveness of implementing a medication therapy management program for improving adherence for patients in a community pharmacy

10-238 - Effects of a comprehensive medication management clinic on high-risk medication use in the elderly

11-350 - Evaluating pharmacist impact on new-start SSRI/SNRI adherence and therapy in adult patients in the primary care setting

13-358 - Evaluating Quality of Care: Analysis of the impact of a clinical pharmacy program on the diabetes care of an underserved population within a medical home

13-372 - Evaluating sacubitril/valsartan prescribing practices in patients with reduced ejection fraction heart failure

9-185 - Evaluating the impact of influenza and streptococcal point of care testing and collaborative practice prescribing in a community pharmacy setting

10-154 - Evaluating the impact of pharmacist-led interventions in an underserved diabetic population

10-119 - Evaluating the impact of pharmacist-led interventions on smoking cessation in an established outpatient medication management clinic

12-008 - Evaluation of a community hospital based pharmacist managed diabetes clinic

9-129 - Evaluation of a pharmacist-driven transitions of care initiative and readmission rates in patients admitted with chronic obstructive pulmonary disease (COPD) exacerbation

11-165 - Evaluation of amiodarone monitoring

10-075 - Evaluation of an indigent care medication provision program on 30-day readmission rates in a community hospital

9-290 - Evaluation of an interdisciplinary workflow for hypertension at a charity patient-centered medical home

10-340 - Evaluation of appropriate prescribing and management of target specific oral anticoagulants (TSOACs) in an internal medicine clinic and the feasibility of expanding current anticoagulation services

10-338 - Evaluation of appropriate prescribing of statin therapy based on ASCVD risk in CMR eligible patients

10-206 - Evaluation of causes and treatment of subtherapeutic international normalized ratios (INRs)

10-050 - Evaluation of COPD metrics for internal medicine clinic patients

9-266 - Evaluation of direct oral anticoagulant use and implementation of a pharmacist-led direct oral anticoagulant telephone clinic in an outpatient federally qualified health center

10-205 - Evaluation of elevated international normalized ratios (INRs) within a pharmacist-run, outpatient, anticoagulation service

12-113 - Evaluation of Medication Management Potential of Pharmacists through Medicare Annual Wellness Visits

11-242 - Evaluation of medication therapy management (MTM) interventions by clinical pharmacists in the ambulatory care setting

10-310 - Evaluation of patient functional status improvement following participation in a pharmacist-guided, non-prescribing, multidisciplinary pain clinic

10-162 - Evaluation of pharmacist involvement in chronic obstructive pulmonary disease inhaler education

11-140 - Evaluation of pharmacist-managed diabetes mellitus under a collaborative clinical pharmacist practitioner agreement in a private rural clinic

9-267 - Evaluation of pharmacotherapy in primary care and provider acceptance of treatment recommendations for patients with heart failure (HF)

13-362 - Evaluation of pharmacy resident-led transitions of care service for patients with heart failure: a single center retrospective cohort study

10-315 - Evaluation of prescribing practices of hormone replacement therapy in women 50 years and older with high cardiovascular risk at a federally qualified health center

10-291 - Evaluation of proton pump inhibitor prescribing patterns in the underserved population

11-161 - Evaluation of risk assessment and documentation for patients on chronic opioid therapy

10-066 - Evaluation of the factors that predict non-participation in a diabetes prevention program

13-371 - Evaluation of the prescribing practices of proton-pump inhibitors in patients with gastroesophageal reflux disease (GERD) and esophagitis in the outpatient setting

9-263 - Expanding the use of pharmacist-managed insulin pumps in a primary care setting

10-173 - Expansion of a transitions of care program in a large, academic pediatric hospital

11-372 - Expansion of pharmacotherapy clinic services to include initiation, management, and monitoring of disease modifying treatments for patients with multiple sclerosis or rheumatoid arthritis

9-197 - Exploring barriers to transition of care clinic visits in a post-stroke population

11-401 - Identification of opportunities for pharmacist intervention for patients with uncontrolled hypertension in the adult primary care setting

13-292 - Identifying osteoporosis care opportunities for pharmacist in a rural clinic setting

12-101 - Impact assessment of a community pharmacy immunization service on vaccination rates and patient satisfaction in Puerto Rico

9-040 - Impact of a clinical pharmacist on the management of diabetes mellitus in the ambulatory care setting of a large teaching hospital

11-177 - Impact of a feedback toolkit for pharmacy preceptors to improve feedback and evaluation completion rates within an ambulatory care residency program

10-280 - Impact of a first-month pharmacist consultation program on adherence to therapy in multiple sclerosis patients new to dimethyl fumarate in a specialty pharmacy setting

9-115 - Impact of a formal training program for Advanced Practice Pharmacist Clinicians on continuous glucose monitoring utilization

10-287 - Impact of a pharmacist and provider collaborative approach to improve initiation of statin therapy among patients with diabetes

13-164 - Impact of a pharmacist-led diabetes management outpatient service in a rural senior community

9-216 - Impact of a pharmacist-led transitions of care program on revenue and readmission rates in a hospital-owned outpatient provider system

13-055 - Impact of a pharmacist-managed diabetes clinic on an underserved population with uncontrolled type 2 diabetes

11-150 - Impact of a pharmacy-physician collaboration on asthma & chronic obstructive pulmonary disease on emergency department visits

11-147 - Impact of a population health pharmacist within a health system

9-281 - Impact of an ambulatory care pharmacist in psychiatric patient care

9-183 - Impact of an ambulatory care pharmacist on outcomes in a family practice clinic

11-289 - Impact of an ambulatory pharmacotherapy clinic in hemoglobin A1C reduction

10-441 - Impact of clinical pharmacist-led diabetes management clinic on patient-related health outcomes at an academic tertiary hospital in Saudi Arabia: a prospective cohort study

12-206 - Impact of group asthma education classes led by a multidisciplinary team in adults for asthma control

12-173 - Impact of Pharmacist Driven Interventions on Inappropriate Antibiotic Prescribing for Upper Respiratory Tract Infections (URTIs) in a Family Medicine Residency Clinic

11-049 - Impact of pharmacist intervention on health services utilization and cost for diabetic patients

9-253 - Impact of pharmacist intervention on hemoglobin A1c in patients with uncontrolled diabetes in rural primary care clinics: a retrospective chart review

11-305 - Impact of pharmacist intervention on pneumococcal conjugate vaccine – 13 valent vaccination rates in a family practice residency clinic

11-395 - Impact of pharmacist involvement in interdisciplinary transitions of care in the primary care setting

11-208 - Impact of pharmacist involvement in transitional care management

12-003 - Impact of pharmacist-led medication reconciliation on drug-related problems and potentially avoidable readmissions in Medicare Advantage patients discharged from the emergency department

10-149 - Impact of pharmacist-led medication review on chronic obstructive pulmonary disease (COPD) 30-day readmission rates in the ambulatory care setting

11-109 - Impact of pharmacists' intervention on reducing readmission rates and mortality in a community hospital congestive heart failure clinic

13-019 - Impact of pharmacist’s intervention with proton pump inhibitor (PPI) prescribing and deprescribing in a primary care setting

12-014 - Impact of pharmacists on medication adherence and prevention of hospital utilizations in an ambulatory care setting

10-012 - Impact of pharmacists on meeting diabetes preventative care measures in community health system outpatient clinics: a matched cohort analysis

12-325 - Impact of pharmacotherapy services on lipid management in diabetic patients

13-228 - Impact of pharmacy services at an outpatient cardiology clinic

11-004 - Impact of physician-pharmacist collaboration for disease state management on patient outcomes

11-402 - Impact of shared medical appointments with a cardiologist and pharmacist on the pharmacologic management of heart failure

11-034 - Impact of vitamin D on pulmonary outcomes and bone health in patients with cystic fibrosis

13-307 - Implementation and evaluation of a chronic obstructive pulmonary disease (COPD) pharmacy-managed clinic in southeastern Kentucky

10-059 - Implementation and evaluation of a patient-centered diabetes education program based on patient preferences

10-153 - Implementation and evaluation of a pharmacist-driven chronic obstructive pulmonary disease care bundle at a community hospital

9-277 - Implementation of a clinical pharmacist driven medication therapy management (MTM) program for uncontrolled hypertension and cholesterol

13-137 - Implementation of a Pharm.D. run medication management clinic in the outpatient setting, targeting high-risk Congestive-Heart-Failure (CHF) patients and impact on admissions/readmissions and emergency-department (ED) utilization

11-370 - Implementation of a pharmacist-led opioid stewardship program in an ambulatory care setting

11-351 - Implementation of a pharmacist-led smoking cessation program in a pulmonology specialty clinic

10-120 - Implementation of a rolling cycle of patient evaluation and education sessions focused on diabetes-related comorbidities in a pharmacist-run ambulatory care clinic

11-388 - Implementation of an ambulatory clinical pharmacist playbook

9-024 - Implementation of comprehensive medication management review in the ambulatory care setting

10-284 - Implementation of pharmacist medication services for heart failure patients

9-147 - Implementation of pharmacist-led oral chemotherapy education in an outpatient oncology clinic

9-392 - Implementation of standard documentation to capture clinical pharmacists’ interventions in a pre-specified elderly population with severe frailty

11-299 - Implementing a pharmacist-led benzodiazepine deprescribing protocol in an outpatient primary care clinic

13-291 - Improvement of diabetes management through health registry surveillance

11-243 - Improving Efficiency through Optimizing Workflow in a Pharmacist-Run Diabetes Clinic

9-029 - Improving the gaps in home medication reconciliation process by implementing standardized education for nurses

9-323 - Increasing naloxone knowledge and use through direct-to-consumer education

11-278 - Interventions to improve work efficacy and decrease burnout of ambulatory care pharmacists

13-252 - Measuring compliance with the diabetes composite quality performance benchmark in a primary care-based accountable care organization: Examining HgA1c goals and diabetic eye exams

11-144 - Medication discrepancies at hospital discharge in patients with type 1 and type 2 diabetes on insulin

11-112 - Medication use evaluation – safe and effective use of benzodiazepines in the elderly population of a primary care setting

13-253 - Meeting the measures: Statin use in diabetic patients in a primary care-based accountable care organization

12-375 - Multicenter retrospective cohort study evaluating antibiotic prescribing patterns for the treatment of urinary tract infections (UTIs) in primary care

11-141 - Optimization of the warfarin management process in a rural primary care clinic

11-393 - Optimizing the pharmacist’s role in a multidisciplinary patient centered chronic pain focused visit

12-028 - Outcomes of a pharmacist-managed psoriasis service

12-341 - Outcomes of a pharmacy-driven transitions-of-care program within a patient-centered medical home

13-204 - Outpatient antimicrobial utilization for upper respiratory conditions

10-166 - Patient preferences regarding vaccinations administered by pharmacists vs registered nurses at MetroHealth outpatient clinics

10-324 - Patient Risk Stratification to Facilitate Pharmacist Provision of Chronic Care Management Services

9-265 - Pharmacist assisted intervention for patients diagnosed with Alcohol Use Disorder in an integrated primary care setting

13-357 - Pharmacist impact on chronic obstructive pulmonary disease (COPD) in a transitions of care pilot program

10-296 - Pharmacist impact on Medicare star ratings for adherence and high risk medication use in the elderly

10-014 - Pharmacist impact on obtaining and maintaining diabetes control in a community health system

9-435 - Pharmacist management of hypertension in an outpatient clinic

12-371 - Pharmacist-developed opioid overdose education and naloxone distribution program in the emergency department of a community hospital: a pilot study

12-318 - Pharmacist-managed asthma clinic for 9/11 responders: a pilot study

10-228 - PHARM-HF: Effect of pharmacist interventions in an outpatient clinic on 30-day readmission rates for heart failure

10-132 - Predictors of 30-day readmission in family medicine patients to identify candidates for transitional care management (TCM) services

10-410 - Pre-exposure prophylaxis (PrEP) education and utilization in an urban family medicine health center

10-167 - Prescribing practices for type 2 diabetes mellitus: results of an online survey

9-382 - Prescribing Trends of Sulfonylureas versus Other Non-Insulin Antidiabetic Agents in the United States from 2009 to 2015

12-346 - Project PACT-STROKE: Pharmacists Act on Care Transitions for Stroke

11-454 - Retrospective chart review comparing a pharmacy-run conservative dosing protocol to manufacturer guidelines for U-100 to U-500R insulin conversions

11-038 - Retrospective Review on Outcomes of Proton-Pump Inhibitor Deprescribing in Medication Therapy Management Patient Population

11-419 - Reviewing current outpatient practices regarding serum potassium monitoring following aldosterone antagonist initiation

12-211 - Role of Pharmacists within a Value-based Healthcare Model

13-121 - Specialty pharmacy: reducing barriers to treatment initiation- a review of internal workflow processes

9-274 - Standardized referral of at-risk hospitalized patients for pharmacist-driven comprehensive medication management in a comprehensive primary care plus clinic: analysis of 30-day hospital readmissions

13-356 - Surveying Kentucky pharmacists’ perspective and barriers on providing post-exposure prophylaxis therapy

11-091 - Targeted strategies to improve population health in a rural community

9-268 - The impact of a pharmacist-led smoking cessation clinic in a fully integrated federally qualified health center serving the homeless or those with housing insecurity

13-262 - The Impact of Motivational Interviewing on Chronic Kidney Disease Identification and Management in Patients with Diabetes Mellitus and Low Socioeconomic Status

10-247 - The impact of University Hospitals Specialty Pharmacy hepatitis C patient management program on patient and pharmacy outcomes

11-273 - Use of a student-driven centralized service to improve adherence rates

11-432 - Use of sacubitril/valsartan for heart failure with reduced ejection fraction (HFrEF) in a safety net population

10-421 - Utilization of three metformin extended release formulations in an urban family medicine residency program

10-273 - A quality assessment of direct oral anticoagulants in an academic medical center

10-299 - A retrospective study to evaluate the impact of sacubitril/valsartan on disease-related outcomes of heart failure patients within an Oregon health-system

13-301 - Adenosine vs. regadenoson: a post-marketing comparison of side effects, cost, and time taken to perform cardiac stress testing: is regadenoson worth the extra cost?

13-171 - Alternative alteplase dosing strategies in the ekosonic endovascular system procedure for treatment of pulmonary embolism

11-437 - Alternative thromboprophylactic dosing of enoxaparin: a retrospective analysis evaluating the need for dose adjustments in obesity

9-346 - Amiodarone for atrial fibrillation: staying on beat with patient safety

12-357 - An Evaluation of Vitamin K (Phytonadione) Dosing Practices: Defining the Pharmacist’s Role on Appropriate Dosing and Cost-saving Initiatives

13-193 - An interdisciplinary initiative to increase inpatient and emergency department prescribing of direct oral anticoagulants for patients with venous thromboembolism: a multisite evaluation

12-376 - Analysis of Heparin Monitoring Protocol Utilizing the Activated Partial Thromboplastin Time vs Anti-factor Xa in an Academic Medical Center

9-207 - Analysis of the time to administration and accuracy of dosing of 4-factor prothrombin complex concentrate at an academic medical center

11-215 - Apixaban and rivaroxaban versus warfarin for the treatment of venous thromboembolism in obese patients

9-149 - Assessing readmission rates for thrombosis in patients discharged on anticoagulation therapy after elective total hip or knee arthroplasty

13-053 - Assessing the prescribing of direct oral anticoagulants compared to warfarin in patients with extremes in body weight

9-307 - Assessing venous thromboembolism prophylaxis in the liver cirrhosis patient population at a large academic medical center

11-172 - Assessment of direct thrombin inhibitor use in heparin-induced thrombocytopenia

13-179 - Assessment of heparin dosing strategies in the cardiac catherization lab for coronary interventions

12-397 - Assessment of multiple variables regarding the correlation between heparin dose and activated clotting time (ACT) in percutaneous vascular intervention angiography

11-085 - Assessment of prescribing patterns of direct oral anticoagulant medications pre- and post- implementation of a pharmacist-led dosing tool

12-383 - Assessment of prescribing patterns of venous thromboembolism prophylaxis after quality improvement interventions at a large, tertiary care, academic medical center: phase 3 of 3

12-130 - Assessment of venous thromboembolism (VTE) prophylaxis strategies in underweight patients

12-232 - Assessment of warfarin and unfractionated heparin overlap in patients with confirmed venous thromboembolism

12-157 - Association between warfarin time in therapeutic range and post-transplant outcomes in heart transplant recipients

9-097 - Attainment of therapeutic anti-factor Xa levels in morbidly obese patients receiving enoxaparin

12-087 - Cangrelor use in an academic medical center: extending beyond the FDA indication

12-102 - Caving Under Pressure: Management of Hypertensive Crisis

9-021 - Characterization of anticoagulation with ventricular assist devices at a single center

12-194 - Cirrhosis, thrombosis, finding faXts about doses: dosing of unfractionated heparin for venous thromboembolism in cirrhosis

13-161 - Clinical Effects of Coaguchek XS PT Test Strips Calibration on Anticoagulation Management Services

9-082 - Comparison of a fixed-dose 4 factor PCC dosing regimen to a weight based regimen for warfarin associated bleeding in a community hospital

10-209 - Comparison of anti-factor Xa and activated partial thromboplastin time protocols for unfractionated heparin monitoring at a tertiary hospital

13-334 - Comparison of hemostatic outcomes in anticoagulated patients receiving fixed dose versus weight based 4-factor prothrombin complex concentrate

10-371 - Comparison of high and low intensity heparin protocols on anticoagulation related complications in patients undergoing extracorporeal membrane oxygenation

10-029 - Comparison of pharmacist versus prescriber 4T score calculation and HIT antibody results

10-321 - Comparison of postoperative complications after total hip or total knee arthroplasty in patients receiving prophylactic antithrombotic agents in a community hospital setting

10-001 - Comparison of two heparin protocols for use in extended percutaneous mechanical circulatory support

9-218 - Describing current practices of pharmacist-driven dose adjustment of prophylactic enoxaparin in medically-ill, obese patients at an academic medical center

10-051 - Designing a comparison study evaluating discharge diuretic dosing and all-cause thirty-day readmission rates in acute decompensated heart failure patients

11-344 - Development of a Comprehensive Anticoagulant Reversal Protocol for a Health System

13-132 - Does renal function affect the safety of direct oral anticoagulants for stroke prevention in atrial fibrillation?

11-092 - Door-to-diuretic time in patients presenting with acute decompensated heart failure (ADHF) and the impact of pharmacist-initiated heart failure patient education at an inner city hospital

9-357 - Effect of adjusted or actual body weight in creatinine clearance calculation on the rates of dofetilide discontinuation or dose reduction during dofetilide initiation

12-192 - Effect of digoxin on right ventricular function in patients with left ventricular assist devices

13-336 - Effect of intensive lifestyle changes on medication therapy for coronary heart disease

12-089 - Effect of peri-procedural heparin versus bivalirudin on bleeding in patients receiving cangrelor for percutaneous coronary intervention at an academic medical center

10-047 - Effect of renin-angiotensin-aldosterone antagonists and beta blockers on cardiac reverse remodeling after transcatheter aortic valve replacement for severe aortic stenosis

9-442 - Effect on Patient Outcomes and Cost Savings After Implementation of a Prothrombin Complex Concentrate (Human)® Dose Standardization and Restricted Use Protocol

11-200 - Effectiveness and safety of metolazone dosing in combination with loop diuretic therapy in acute decompensated heart failure

11-204 - Effects of intravenous morphine administration on readmission rates during acute myocardial infarction in a community hospital

13-221 - Efficacy and safety of systemic heparin and bivalirudin in adult patients supported by extracorporeal membrane oxygenation

13-102 - Efficacy of established direct oral anticoagulants in obese patients

9-424 - Efficacy of heparin protocols with and without boluses

10-025 - Efficacy of twice-daily aspirin versus direct-acting oral anticoagulants for the prevention of deep venous thrombosis and pulmonary embolism after orthopedic surgery

9-411 - Evaluating argatroban use and a rapid laboratory test to detect heparin-induced thrombocytopenia: a pharmacy and laboratory collaboration

13-112 - Evaluating Direct Oral Anticoagulant Prescribing Practices and Impact on Patient Outcomes

9-038 - Evaluating the appropriateness of enoxaparin dosing for venous thromboembolism prophylaxis in obese patients

9-308 - Evaluating the characteristics and outcomes of prescribing practices of direct oral anticoagulants vs. vitamin K antagonist for therapeutic anticoagulation in obese patients

12-124 - Evaluating the clinical interpretation of the anti-platelet factor 4 assay (PF4 ELISA) in the absence of reported optical density units

9-233 - Evaluating the dual impact of dose and time to administration of IV loop diuretics in acute heart failure patients

9-249 - Evaluating the outcomes associated with adjusted enoxaparin dosing versus non-adjusted enoxaparin dosing in obese patients requiring therapeutic anticoagulation

9-413 - Evaluating the safety and efficacy of direct oral anticoagulants (DOACs) in patients weighing over 120 kilograms

13-395 - Evaluating the safety and efficacy of pharmacist and physician dosing and monitoring of warfarin at a three-campus community hospital

11-052 - Evaluating the safety and efficacy of transitioning from a fixed-dose protocol to a weight-based protocol for heparin infusion and titration

9-055 - Evaluating the safety of anticoagulation in thrombocytopenia

11-058 - Evaluating the safety of catheter-directed thrombolysis in patients with deep vein thrombosis, pulmonary embolism, peripheral arterial disease, or peripheral vascular disease

12-374 - Evaluating the use of QT prolonging medications in hospitalized patients

12-125 - Evaluating use of direct oral anticoagulants (DOACs) in patients with cardiac thrombus

10-064 - Evaluation of 4-factor prothrombin complex concentrate administration

9-258 - Evaluation of a bivalirudin dosing nomogram for heparin-induced thrombocytopenia

11-188 - Evaluation of acute care patients previously taking oral factor Xa inhibitors and experiencing lab interference when transitioning to parenteral anticoagulation

11-222 - Evaluation of adherence rates of guideline-directed management and therapy (GDMT) using current guidelines for the management of heart failure

10-252 - Evaluation of an amiodarone dosing strategy for the prevention of postoperative atrial fibrillation at an academic medical center

12-270 - Evaluation of an unfractionated heparin dosing protocol in obese patients: a retrospective review

9-255 - Evaluation of anticoagulation in patients with atrial fibrillation admitted with acute ischemic stroke

12-382 - Evaluation of anticoagulation practices with a percutaneous ventricular assist device

10-409 - Evaluation of apixaban and rivaroxaban effectiveness in stroke prevention in morbidly obese atrial fibrillation patients

12-111 - Evaluation of apixaban utilization in hemodialysis patients with atrial fibrillation

13-380 - Evaluation of bivalirudin anticoagulation in patients receiving extracorporeal membrane oxygenation at an academic medical center

11-309 - Evaluation of bleeding and thrombotic risk in patients receiving triple antithrombotic therapy

13-248 - Evaluation of direct oral anticoagulant (DOAC) treatment failure and associated risk factors in patients with class III obesity

9-091 - Evaluation of direct oral anticoagulants in obese and extremely obese patients

10-090 - Evaluation of diuretic dose modification at discharge and 30-day readmission rate in heart failure with preserved ejection fraction

13-247 - Evaluation of Erythropoietin Stimulating Agents (ESAs) and its efficacy on blood optimization for cardiothoracic surgery

11-254 - Evaluation of fixed-dose four-factor prothrombin complex concentrate within a community health system

12-279 - Evaluation of four-factor prothrombin complex concentrate use in patients with chronic liver disease

11-234 - Evaluation of heparin drips in obese patients at an academic medical center

9-122 - Evaluation of native state thrombophilia testing within an academic teaching hospital

11-066 - Evaluation of pharmacist counseling for heart failure patients on readmissions at a community teaching hospital

11-186 - Evaluation of pharmacist review of direct oral anticoagulants in the inpatient setting

10-434 - Evaluation of Pharmacist-managed anticoagulation clinic compared to Hematologist-managed anticoagulation Clinic in a Tertiary Hospital in Saudi Arabia

10-233 - Evaluation of Pharmacy recommended anticoagulation post orthopedic surgery for patients who were on direct oral anticoagulation or warfarin prior to surgery

12-204 - Evaluation of prescribing patterns of direct oral anticoagulants at an academic medical center

11-013 - Evaluation of prophylactic enoxaparin dosing in morbidly obese patients at an integrated healthcare system

12-224 - Evaluation of Recombinant Factor VIIa dose for perioperative bleeding in patients requiring cardiopulmonary bypass

13-075 - Evaluation of Regadenoson Utilization at a Community Teaching Hospital

12-296 - Evaluation of sacubitril/valsartan utilization in a teaching hospital

12-042 - Evaluation of sacubitril/valsartan’s effect on hemoglobin A1C, ejection fraction, and/or psychological issues in patients with congestive heart failure at a multidisciplinary clinic

13-290 - Evaluation of subcutaneous heparin utilization for venous thromboembolism prophylaxis in hospitalized obese patients

13-376 - Evaluation of the appropriate use of statins in patients hospitalized for acute coronary syndrome at a community hospital

11-063 - Evaluation of the concomitant use of direct oral anticoagulants and strong CYP3A4/P-gp inducers or inhibitors

9-168 - Evaluation of the effectiveness of heparin dosing protocol in patients with Impella devices

12-009 - Evaluation of the Efficacy and Safety of Alteplase for the Treatment of Pulmonary Embolism

10-245 - Evaluation of the impact of achieving at least 50 percent of target doses of select beta blockers in patients with heart failure on hospitalizations

13-050 - Evaluation of the management of intravenous unfractionated heparin infusions using percentage of partial thromboplastin times in the therapeutic range

10-226 - Evaluation of the safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease

12-137 - Evaluation of the transitioning process between parenteral unfractionated heparin products and direct oral anticoagulants at the Henry Ford Health System

12-242 - Evaluation of the Use of Loop Diuretic Dosage Adjustments After Initiation of Angiotensin-Neprilysin Inhibitor in Heart Failure Patients

12-205 - Evaluation of therapeutic enoxaparin dosing on anti-Xa levels in obese patients

11-293 - Evaluation of thromboembolic events after implementation of the Padua Prediction Score (PPS) among a general medicine patient population

13-023 - Evaluation of time in therapeutic range and major adverse events due to warfarin experienced by patients in a pharmacist-run anticoagulation clinic

9-433 - Evaluation of weight-based versus flat loading dosing of digoxin

10-290 - Factors associated with direct oral anticoagulant (DOAC) treatment failure

9-429 - Factors associated with inappropriate inpatient apixaban prescribing practices

10-388 - Feasibility of therapeutic unfractionated heparin monitoring utilizing anti-factor Xa compared to activated partial thromboplastin time

13-281 - Fixed versus weight-based dosing of 4- factor prothrombin complex concentrate for the reversal of vitamin-k antagonist: a multi-center, retrospective analysis

13-258 - Fixed-dose activated prothrombin complex concentrate (aPCC) for oral factor Xa inhibitor reversal

10-270 - Guideline-directed medical therapy in long-term care facility patients with heart failure

10-079 - Heparin management for the Impella ventricular assistance device

10-033 - Heparin Resistance: Identification of Risk Factors

11-292 - Identification of risk factors contributing to venous thromboembolism (VTE) after orthopedic trauma and utilization of a standardized VTE prophylaxis algorithm for orthopedic trauma patients

12-381 - Impact of a novel specialty pharmacy referral program on direct oral anticoagulant (DOAC) prescribing and patient satisfaction

9-011 - Impact of a pharmacist-managed direct oral anticoagulation stewardship program: a pilot study

11-028 - Impact of a pharmacy-led anticoagulant and antiplatelet medication counseling program in an acute care hospital

13-270 - Impact of an inpatient pharmacist-managed warfarin maintenance protocol on time in therapeutic range

12-245 - Impact of audio/visual medication counseling in patients’ native languages on understanding of anticoagulant medications

9-108 - Impact of body mass index (BMI) on 90-day warfarin requirements: a retrospective chart review

11-303 - Impact of heart failure transitions of care program: a prospective study of heart failure education and patient satisfaction

13-265 - Impact of implementing a periprocedural protocol for the management of antithrombotic agents in an acute care community hospital

12-248 - Impact of pharmacist intervention on medication literacy and adherence in cardiac patients

13-014 - Impact of pharmacist interventions for heart failure patients with reduced left ventricular ejection fraction in a community-based teaching hospital

12-062 - Impact of switching poorly controlled patients on warfarin to rivaroxaban – focus on adherence and workflow

13-096 - Impact of using a congestive heart failure electronic scoring tool: an assessment of 30 day readmission rates

12-132 - Implementation and evaluation of a direct oral anticoagulant (DOAC) management service in the anticoagulation clinic

11-340 - Implementing a pharmacokinetic (based on anti-factor Xa) adjusted enoxaparin dosing protocol for Trauma patients

11-318 - Incidence of heparin-induced thrombocytopenia at a 443-bed acute care hospital

11-203 - Incidence of postoperative atrial fibrillation associated with the use of dopamine after cardiac surgery

12-403 - Incidence of successful supraventricular tachycardia induction with epinephrine versus isoproterenol for patients undergoing ablation therapy in the electrophysiology laboratory

10-026 - Incidence of thrombotic events in obese patients treated with direct-acting oral anticoagulants (DOACs)

10-356 - Incidence of venous thromboembolism (VTE) after administration of prothrombin complex concentrate (human)

11-106 - Is heparin per pharmacy better at achieving therapeutic levels than nursing using a nomogram?

12-226 - Low intensity heparin infusion bleed risk and outcomes analysis

11-256 - Medication use evaluation of human 4-factor prothrombin complex concentrate

9-230 - Methylprednisolone in addition to beta-blocker or amiodarone for prevention of postoperative atrial fibrillation (POAF) in coronary artery bypass graft surgery (CABG)

11-346 - Monitoring and adjusting unfractionated heparin infusions for patients previously on oral factor Xa inhibitors

13-260 - Nicardipine versus clevidipine and nitroprusside for postoperative hypertension after open heart surgery

13-143 - Ongoing evaluation of the impact of a post-operative atrial fibrillation prevention protocol for patients undergoing cardiothoracic surgery

11-074 - Optimization and standardization of heparin infusion protocols across a state-wide hospital system: a retrospective analysis to determine factors influencing time in therapeutic range

13-285 - Outcomes after use of four-factor prothrombin complex concentrate for reversal of DOAC-associated bleeding

9-426 - Outcomes Associated with Optimization of Guideline Directed Medical Therapy (GDMT) in Patients Admitted for an Acute Heart Failure Exacerbation

11-327 - Outcomes of an Inpatient Pharmacist-Driven Warfarin Protocol in a Community Hospital Setting

10-451 - Outcomes with rivaroxaban as a part of triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention

12-263 - Periprocedural Interruption of Direct Oral Anticoagulants for Percutaneous Coronary Intervention

13-251 - Pharmacist Driven Medication Reconciliation Program Targeted to Patients with a Primary Diagnosis of Acute Decompensated Heart Failure

12-293 - Platelet function p2Y12 testing use in assessing the risk for hemorrhage in patients on clopidogrel

11-168 - Post-operative venous thromboembolism (VTE) prophylaxis in total hip and total knee arthroplasty

12-278 - Prescribing pattern and appropriateness of anticoagulation in new onset non-valvular atrial fibrillation in hospitalized older adults

11-162 - Readmission Rates in Patients Receiving Triple Antithrombotic Therapy

12-343 - Real-world experience with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors at a university specialty pharmacy

9-124 - Retrospective analysis of an antithrombosis de-escalation protocol in a pharmacist-run, hospital-based clinic

11-436 - Retrospective analysis of the safety and efficacy of a reduced infusion rate heparin protocol for the treatment of venous thromboembolism

9-164 - Retrospective analysis of weight-based versus standard dose diltiazem in the acute treatment of atrial fibrillation in a community hospital

9-051 - Retrospective evaluation of remote dielectric sensing (ReDS) vest technology and its impact on heart failure readmission rates and diuretics therapy

13-243 - Retrospective medication use evaluation of continuous heparin infusions in a community hospital setting

13-144 - Retrospective review of patients treated with argatroban for heparin induced thrombocytopenia

11-017 - Retrospective review of the evaluation and treatment of patients with suspected heparin-induced thrombocytopenia

10-156 - Retrospective study of an unfractionated heparin dosing protocol in venous thromboembolism in the morbidly obese

9-138 - Review of appropriate dosing of direct oral anticoagulants

12-047 - Review of outcomes using 4-factor prothrombin complex concentrate fixed dosing regimen versus standard dosing

9-384 - Review of the outcomes data on the use of direct oral anticoagulation in solid organ transplant patients

12-353 - Safety and effectiveness of accelerated intravenous sodium ferric gluconate complex administration in heart failure patients

12-333 - Safety and effectiveness of fixed dose four-factor prothrombin complex concentrate at a 351-bed community hospital

9-078 - Safety and efficacy of apixaban in patients with venous thromboembolism and end-stage renal disease

12-239 - Safety and efficacy of Kcentra for the reversal of oral factor Xa inhibitor-associated bleeding

12-365 - Safety outcomes of a new anticoagulation management service for patients on novel anticoagulants, a pre- and post-interventional analysis

12-144 - Single-center retrospective analysis evaluating the safety and efficacy of a pharmacist-managed inpatient warfarin dosing service

11-230 - Sotalol monitoring during initiation of therapy

13-167 - Standardization of enoxaparin dose to 40mg daily in post-operative orthopedic patients

9-201 - System-wide evaluation of sotalol use

13-359 - Target-specific oral anticoagulant use in morbid obesity and rates of venous thromboembolism and stroke

9-315 - The effect of an integrated heparin calculator on time to therapeutic activated partial thromboplastin time (aPTT)

10-092 - The efficacy and safety of non-vitamin K oral anticoagulants following cardiac valve replacement

9-128 - The Impact of Oral Diuretic Transition Prior to Hospital Discharge on Heart Failure Readmission Rates

10-440 - The pattern of direct oral anticoagulant use in Saudis' clinical practice, a retrospective cross sectional descriptive study

9-127 - Timing of initial intravenous loop diuretic dose in heart failure exacerbation

13-177 - Use of apixaban in valvular atrial fibrillation in cardiothoracic surgical patients

13-057 - Use of direct oral anticoagulants compared to warfarin in the obese population

10-241 - Use of intravenous iron in patients admitted with heart failure

11-274 - Use of warfarin versus direct oral anticoagulants in obese individuals for the treatment of venous thromboembolism: a retrospective chart review

13-062 - Utilization of rivaroxaban in overweight/obese patients at Cook County Hospital and Healthcare System (CCHHS)

10-021 - Venous thromboembolism (VTE) occurrence in obese patients versus non-obese patients taking direct oral anticoagulants (DOACs)

12-338 - Venous thromboembolism prophylaxis usage at a community teaching hospital

9-239 - Acceptance of pharmacist-recommended inhaled corticosteroids by primary care providers managing pediatric Medicaid beneficiaries in a managed care organization

10-268 - Acute exacerbations of asthma and chronic obstructive pulmonary disease management: a look at outcomes with ipratropium/albuterol dosing frequencies of “around the clock” versus “while awake”

11-252 - Assessing the impact of medication compliance packaging on hemoglobin A1c in diabetic patients receiving oral antiglycemic medications

12-120 - Clinical outcomes of switching patients to preferred short-acting/rapid-acting insulin products among a commercially insured population

9-362 - Effect of telephonic first-fill counseling for medications received via home delivery on adherence and patient satisfaction in a community pharmacy setting

9-316 - Effects of prescribing COPD rescue kits on hospital readmissions

12-026 - Eradication of hepatitis C virus: how does this affect glycemic control in patients with type 2 diabetes mellitus?

12-099 - Evaluate the clinical effectiveness of an interdisciplinary collaborative care in poor controlled diabetes type 2 patients

10-386 - Evaluating the impact of a nurse case manager-led program on a hemophilia population

9-269 - Impact of a Medicare Advantage (MA) chronic condition special needs plan (C-SNP) on medication adherence and health care utilization outcomes

10-278 - Impact of a medication synchronization program on medication adherence and clinical outcomes in a refugee population

12-044 - Impact of anti-tumor necrosis factor (TNF) therapy site of care on inflammatory bowel disease outcomes in adults and children

11-251 - Implementation and evaluation of comprehensive education of diabetes to improve statin therapy initiation in diabetic patients

10-380 - Implementation of a pharmacist-led transitions of care (TOC) program for chronic obstructive pulmonary disease (COPD) in a community teaching hospital

10-385 - Long-acting insulin formulary change and impact on health care utilization and cost in a Medicaid population

12-022 - Oncology Bundled Payment Model: Adherence to Recommended Cancer Treatment Pathways and Drug Utilization in an Independent Practice Association (IPA)

11-342 - Patient Characteristics Impacting the Utilization of MyChart Messaging: A Descriptive Analysis

13-414 - Pharmacist led cost effectiveness intervention analysis of a Level Funded Healthcare Plan in T2DM

13-296 - Pharmacoeconomic analysis of direct oral anticoagulants compared to warfarin in a managed care setting

9-100 - The Impact of a Pharmacy-Based Transitions of Care Program on Heart Failure 30-Day Readmission Rates in a Community Hospital

9-250 - The implementation of pharmacist-led medication therapy management program in Washington, DC Medicaid beneficiaries with hypertension

9-381 - Use of a diabetes decision tree to evaluate the effectiveness of a pharmacist-run diabetes clinic on patient outcomes

11-151 - Analysis of a pharmacy resident-driven transitions of care service at a community teaching hospital

12-148 - Analysis of current state transitions of care processes for heart failure patients at a community hospital and potential role of the pharmacist

12-040 - Analysis of QTc Monitoring Best Practice Alert Integrated into an Electronic Health Record at a Large Academic Medical Center

11-059 - Analysis of the efficacy of pneumococcal vaccine in a community pharmacy setting

10-093 - Assessing outcomes of a newly initiated multidisciplinary culture-review process in the emergency department

11-443 - Assessing patient satisfaction with comprehensive patient care services in a centralized specialty pharmacy

13-195 - Assessing pharmacist discharge medication reviews on 30-day hospital readmission rates in patients discharged to skilled nursing facilities

13-410 - Assessing the impact of a pharmacist led transitions of care team during hospital discharge

9-156 - Assessment of clinical pharmacist productivity and return on investment after implementation of real-time clinical surveillance technology

10-009 - Assessment of dedicated clinical pharmacist transitions of care services in a rural community hospital targeting patients with congestive heart failure

13-277 - Assessment of pharmacist competency during cardiopulmonary arrest code participation in a community hospital

10-254 - Assessment of pharmacist-led warfarin dosing versus non-pharmacist warfarin dosing in an Academic Medical Center

11-160 - Assessment of pharmacy bundle services on hospital readmission of congestive heart failure (CHF) and acute myocardial infarction (AMI) patients

11-250 - Clinical impact and patient perception of pharmacist initiated diabetes self-management education (DSME) in a community-based pharmacy setting

12-023 - Confronting the opioid epidemic through implementation of a pharmacist driven emergency department education program on alternatives to opioids for painful conditions

10-230 - Conversion to a central order processing model: impact on turnaround time, clinical outcomes, employee and patient satisfaction

10-058 - Current utilization of clinical pharmacists in the emergency department at United States academic medical centers

11-288 - Evaluating the impact of a pharmacy patient assistance coordinator at a community hospital

12-422 - Evaluation of a diabetic ketoacidosis protocol at a rural community hospital

12-200 - Evaluation of a specialty hepatitis C virus (HCV) pharmacy service

11-441 - Evaluation of a specialty pharmacy technician-led adherence program

13-311 - Evaluation of an alvimopan stewardship program

11-398 - Evaluation of Clinical Pharmacist Services in Inflammatory Bowel Disease Management: A Patient-Centered-Care Model

12-139 - Evaluation of pharmacist diabetes transition of care consults for intensive care unit patients

13-146 - Evaluation of Pharmacy-led discharge counseling in patients at high risk of readmission

10-055 - Evaluation of staff utilization of a pharmacy driven vancomycin dosing and therapeutic drug monitoring protocol at an academic medical center

11-253 - Evaluation of targeted pharmacist education on HIV medication adherence rates

12-036 - Evaluation of the predictive strength of a novel risk assessment tool in identifying patients at high risk of hospital readmission

10-297 - Evaluation of transition of care pharmacy services

11-142 - Evaluation of using a patient specific readmission risk score to target transitions of care services in a community hospital

11-442 - Examination of a community pharmacy-based type 2 diabetes mellitus education and management program on changes in patient outcomes

10-098 - Expanded pharmacist coverage in the emergency department: What value did we add and what are we still missing?

12-253 - Expanding pharmacist discharge counseling in patients with heart failure: a process improvement initiative

10-317 - Identification of specific patient populations to optimize the impact of pharmacist-led medication histories in a community hospital

10-436 - Identifying Gaps and Pharmacist involvement in Transitioning of Care from Hospital to Home at Tertiary Hospitals in Jeddah, Saudi Arabia

9-391 - Identifying strategies for adherence improvement and intervention implementation: an assessment of pharmacy team perceptions

10-139 - Impact of a chronic obstructive pulmonary disease (COPD) exacerbation order set on hospital length of stay in a community hospital

12-243 - Impact of a clinical pharmacist on a trauma/general surgery service at a level 1 trauma center

11-328 - Impact of a pharmacist led Collaborative Practice Agreement for the management of chemotherapy induced nausea and vomiting (CINV) in a community oncology setting

10-111 - Impact of a pharmacist-driven outpatient antimicrobial management service on hospital readmission rates and length of stay

11-205 - Impact of a pharmacy-led Clostridium difficile infection therapy protocol in a community hospital

11-271 - Impact of area under the concentration-time curve (AUC) based vancomycin drug monitoring approach on achievement of therapeutic goals

13-219 - Impact of decentralized clinical pharmacists on the discharge of patients with high risk medications

13-008 - Impact of educational interventions for providers on appropriate prescribing and monitoring of patients on long-term opioid pain management

10-435 - Impact of implementation of insulin computerized order set for the control of hyperglycemia in hospitalized cardiac patients with type II diabetes mellitus

12-336 - Impact of pharmacist consult and intervention on 30-day readmission rates for patients with a reduced ejection fraction less than or equal to 40 percent

11-267 - Impact of pharmacist incorporation in a transdisciplinary transition of care team on 30-day readmission rates of high risk patients

12-405 - Impact of pharmacist interventions and counseling at discharge on 30-day readmission rate for congestive heart failure patients in a rural healthcare setting

9-423 - Impact of pharmacist-delivered inpatient medication counseling on 30-day readmission rates

12-091 - Impact of pharmacist-facilitated interventions on 30-day heart failure readmission rates as part of a multi-disciplinary transitions-of-care program

10-097 - Impact of pharmacist-led medication counseling on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores

12-406 - Impact of Procalcitonin Guided Antimicrobial Therapy Within a Rural Community Hospital

13-267 - Impact of the layered learning practice model (LLPM) on IV to PO conversion assessments in an inpatient community hospital

10-103 - Implementation and evaluation of a pharmacist driven medication reconciliation service in an academic medical center

9-251 - Implementation of a community pharmacy-led transitions of care service on reducing 30-day readmission in patients with chronic obstructive pulmonary disease (COPD)

11-312 - Implementation of a Medication Hotline to reduce post-discharge medication events

9-188 - Implementation of a meds-to-beds and post discharge follow-up phone call service in a community hospital

12-095 - Implementation of a Meds-to-Beds program for post-PCI patients on dual antiplatelet therapy

12-304 - Implementation of a multi-dose medication dispensing for discharge (MMDD) program for asthma and chronic obstructive pulmonary disease (COPD) patients

9-375 - Implementation of a pharmacist-managed transitions of care service in patients’ preferred language in a Spanish speaking community

12-093 - Implementation of a respiratory therapy bronchodilator adjustment protocol based on patient-response

13-264 - Implementation of a transitions of care pharmacist in an acute care community hospital

10-263 - Implementation of pharmacogenomics dosing guidance for psychiatric medications beyond the current Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines

11-381 - Implementing a collaboratively managed, pharmacist directed, hepatitis C treatment clinic

11-107 - Implementing a pharmacist driven medication therapy management service at St. Luke’s Magic Valley

10-262 - Implementing a pharmacy-driven therapy management program for ambulatory patients utilizing specialty pharmacy medications

11-368 - Improving transitions of care: optimization of pharmacy-driven medication reconciliation services

12-399 - Incidence and severity of hypoglycemia with a pharmacist-managed basal insulin protocol compared to usual care in a multi-hospital system

9-065 - Increasing utilization and healthcare team involvement in a transitions of care meds-to-beds program

12-360 - Initiation of an admission medication reconciliation service focused on high risk Congestive Heart Failure patients utilizing the systems approach in a community hospital

12-401 - Inpatient glycemic control with a pharmacist-managed basal insulin protocol compared to usual care in a multi-hospital system

11-373 - Interdisciplinary collaboration to expand and optimize current clinical services for behavioral health patients

11-375 - Interdisciplinary rounding to reduce heart failure readmissions an improve goal-directed medication therapy

10-307 - Intravenous Opioid Shortages: Assessing the Impacts of Pharmacy Interventions on Opioid Utilization and Patient Safety

9-410 - Modification and reassessment of a pharmacy resident rotation integrated into a family medicine rounding service to enhance resident learning experiences

13-421 - Multidisciplinary approach to improve alcohol withdrawal management in a community hospital setting

10-244 - Ohio pharmacists knowledge and utilization of the patient care process

11-359 - Optimizing communication and interventions in a pharmacist led transitions of care program

11-037 - Perception of pharmacists’ prescriptive authority for smoking cessation medications among patients, prescribers, and pharmacists

11-044 - Pharmacist initiated discharge counseling in high-risk patients

11-403 - Pharmacist led management of acute postoperative pain for patients with total hip replacement

9-420 - Pharmacist-led approach to minimize medications errors using medication reconciliation post-discharge and at follow-up

9-213 - Provider response rates to different formats of medication refill requests for medicine on time (MOT) program participants

12-366 - Real-time pharmacy monitoring for venous thromboembolism (VTE) prophylaxis in a community-hospital setting: Revitalization of the intervening process

11-325 - Retrospective review of 30-day readmission rates of discharged patients to identify benefits of a discharge pharmacist

9-192 - Vancomycin dosing service evaluation

13-108 - A comparison of albumin replacement with 4 g/L versus 8 g/L for large-volume paracentesis in cirrhotic patients

11-095 - Addressing barriers to outpatient insulin adherence during transitions of care

11-239 - Analysis of the etiologies and causative medications in hospital-acquired acute kidney injury

13-184 - Assessing impact of a pharmacist-directed erythropoietin stimulating agent dosing protocol at an outpatient community hospital dialysis unit

12-019 - Assessing the impact of a pharmacist-led in-service on appropriate antimicrobial utilization in a community hospital

9-401 - Assessment of current prescribing practices of adult non-intensive care unit electrolyte replacement in a Midwest tertiary care hospital

10-260 - Clinical outcomes in patients following a switch from the infliximab originator to a biosimilar product

12-363 - Comparison of chlordiazepoxide and lorazepam in symptom-triggered regimens for alcohol withdrawal syndrome: a retrospective cross-site analysis

10-133 - Comparison of continuous versus intermittent pantoprazole dosing in upper gastrointestinal bleeding: A retrospective cohort

12-282 - Deprescribing chronic Proton Pump Inhibitor use to prevent long term adverse events

11-345 - Developing a standard process for renal function assessment and medication dose adjustment

13-052 - Diabetic ketoacidosis: a retrospective evaluation of time to resolution

9-327 - Dosing and monitoring of vancomycin therapy using area-under the curve to minimum inhibitory concentration ratio vs. trough-based measurements

10-246 - Effect of average inpatient blood glucose greater than 140mg/dL on patient outcomes

11-307 - Effect of compliance of enhanced recovery after surgery (ERAS) protocols on pain control at a community medical center

10-077 - Effect of enhanced recovery after surgery (ERAS) in colorectal patients in a large community hospital

10-008 - Effectiveness of guideline assisted antibiotic therapy in patients diagnosed with an uncomplicated urinary tract infection (UTI) in an emergency department setting

10-447 - Efficacy and Safety of Daclatasvir and Asunaprevir Combination Therapy in Elderly Chronic Hepatitis C Patients

13-377 - Evaluating diabetic ketoacidosis protocol usage

10-401 - Evaluating the effectiveness of multidisciplinary inhaler optimization on 30-day hospital readmissions for patients with chronic obstructive pulmonary disease

12-362 - Evaluating the efficacy of gradual dose reduction (GDR) for reducing antipsychotic medication use in nursing home patients: a single center retrospective study

10-181 - Evaluating the impact of GLP-1 agonists on metabolic changes in patients with type 2 diabetes and intensive insulin regimens

13-352 - Evaluating the incidence and outcomes of hepatitis C through pharmacist-led screenings in an opioid-use disorder protocol program

10-243 - Evaluating the potential role of statin therapy in the reduction of gentamicin-induced nephrotoxicity: A retrospective cohort study

13-178 - Evaluating the use of anti-Xa levels to monitor enoxaparin in obese and morbidly obese patients in a community hospital setting

13-162 - Evaluating the use of patiromer for management of hyperkalemia within a community hospital health-system

10-333 - Evaluation of chronic obstructive pulmonary disease regimens upon discharge

9-294 - Evaluation of clinical inertia and follow-up in patients with poorly controlled diabetes

13-037 - Evaluation of diabetic ketoacidosis outcomes after implementation of a standardized diabetic ketoacidosis guideline at a five hospital health-system

13-389 - Evaluation of epoetin use in chronic kidney disease at an academic medical center

13-051 - Evaluation of outcomes associated with aspirin 81 mg twice daily for venous thromboembolism (VTE) prophylaxis in patients following total-knee arthroplasty (TKA) or total-hip arthroplasty (THA)

9-154 - Evaluation of pharmacist intervention on length of therapy and appropriate use of stress ulcer prophylaxis

9-211 - Evaluation of risk factors for development of hypoglycemia in patients with diabetic ketoacidosis while on a continuous intravenous insulin infusion

11-134 - Evaluation of selective serotonin reuptake inhibitors and their impact on the incidence and severity of intracranial and gastrointestinal bleeding

9-390 - Evaluation of the impact of accurately administered antibiotics on length of hospital stay

10-250 - Evaluation of the safety and efficacy of metformin use in hospitalized, non-critically ill patients

12-258 - Evaluation of Vitamin K Usage during Pulmonary Exacerbation in Adult Cystic Fibrosis

10-450 - Evidence-based Deprescribing of Proton Pump Inhibitors: Outcomes of an Interdisciplinary Approach in a Tertiary Care Center in the UAE

12-307 - Impact of a pharmacist driven insulin dosing protocol on the incidence of hypoglycemic events

11-445 - Implementation of a pharmacy dosing consult for insulin glargine in an acute care community hospital

13-072 - Implementation of an enhanced recovery after surgery (ERAS) protocol in bariatric surgical patients to decrease post-operative nausea and vomiting: a retrospective chart review

12-082 - Implementing pharmacist driven glycemic control to evaluate patient days within target range and malglycemia

10-418 - Incidence of hypoglycemia in the setting of acute kidney injury in general medicine patients receiving basal insulin

11-276 - Intrapleural alteplase (tPA) and dornase alfa for the treatment of pleural effusions and empyema

9-354 - Length of stay (LOS) evaluation in patients treated with lactulose vs. lactulose plus rifaximin for the initial treatment of overt hepatic encephalopathy (HE)

12-310 - Management of tolvaptan using an evidence-based order set and its role in improving safe tolvaptan use

13-128 - NO-COPS: naloxone and opiate co-prescribing strategies in a family medicine residency program

13-304 - Outcomes of pharmacy based program to decrease use of sulfonylureas in hospitalized patients

12-220 - Pharmacist driven intervention using spironolactone in heart failure with preserved ejection fraction

12-385 - Potential role of community pharmacists in identifying gaps in cardiovascular disease risk management and vaccine recommendations in patients with diabetes

13-249 - Prescribing patterns of multiple chronic medications that can prolong the QT interval in an indigent population in South Florida

9-229 - Rectal Indomethacin for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients

9-414 - Retrospective review of insulin dose reduction required on hospital admission

10-378 - Review of as needed antihypertensive use in the hospital setting

9-042 - Safety and efficacy of intravenous insulin aspart for the treatment of hyperkalemia: preliminary results

11-279 - Standard versus high-dose enoxaparin for venous thromboembolism prophylaxis in morbidly obese patients

12-100 - Effect of topical diltiazem gel at 2 percent on management of levator ani syndrome

13-370 - Evaluation concerning testing utilization, prescription medications, and over the counter supplements following a diagnosis of Alzheimer’s disease

9-235 - 23.4 Sodium Chloride Versus Mannitol for the Reduction of Intracranial Pressure

10-223 - A retrospective evaluation of midodrine as a vasopressor-weaning agent in cardiovascular intensive care unit patients

11-425 - A single centre randomized controlled trial to evaluate dronabinol for acute pain management in adults with traumatic injury

11-408 - Adherence to analgesia-first sedation in the adult intensive care unit (ICU)

13-174 - Analysis of dose differences of quetiapine in the management of delirium in the intensive care unit

12-349 - Anti-factor Xa Monitoring of Unfractionated Heparin in Patients on Extracorporeal Membrane Oxygenation (ECMO)

12-179 - Antimicrobial use in cardiac surgery patients with delayed sternal closure

11-073 - Assessing a diabetic ketoacidosis order set to improve safety and clinical outcomes within an integrated health system

13-337 - Assessing outcomes in congestive heart failure patients presenting with septic shock receiving standard versus reduced initial fluid resuscitation volume

13-335 - Assessing the effectiveness of modafinil as an adjunctive therapy to assist in the weaning of mechanical ventilation

9-061 - Assessing the use of procalcitonin in critically-ill patients with sepsis or septic shock

12-218 - Assessment and efficacy of current alcohol withdrawal syndrome protocol

9-257 - Assessment of dyskalemia with pentobarbital administration using a monitoring protocol

12-332 - Assessment of intravenous ascorbic acid, thiamine, and corticosteroids for the treatment of sepsis in a 351 bed community teaching hospital

10-015 - Assessment of intravenous sodium bicarbonate use in critically-ill patients with an acute kidney injury for the treatment of acidosis

12-123 - Assessment of vancomycin dosing in critically ill patients on continuous renal replacement therapy

12-135 - Augmented renal clearance in the surgical intensive care unit

10-200 - Barriers to Sepsis Fluid Resuscitation Compliance: Evaluating High-Risk Patients and Fluid Resuscitation Strategies

13-226 - Benzodiazepine-sparing protocol for the management of alcohol withdrawal syndrome in the critically ill

9-016 - Can implementation of a strict protocol for the use of angiotensin II result in better efficacy outcomes in vasodilatory shock?

9-052 - Categorizing Administration Practices for Vasopressors at Community Medical Centers

10-267 - Characteristics of neostigmine use for ileus in trauma intensive care unit patients

9-301 - Clinical Efficacy of Adjunctive Dexmedetomidine Use in the Treatment of Alcohol Withdrawal as Compared to Symptom-Triggered Therapy in Critically Ill Patients

13-093 - Clinical Impact of an Enteral Opiate Optimization Program in the Adult MICU Setting (COELOM)

11-275 - Clinical outcomes associated with the use of phenobarbital in patients with alcohol withdrawal syndrome

9-036 - Clinical outcomes of patients requiring reversal of acute major bleeds caused by rivaroxaban or apixaban

13-280 - Clinical pharmacist integration into the rapid response team at a community hospital

13-103 - Code sepsis rapid response: implementation of a pharmacist and nurse driven protocol

10-096 - Comparing the choice of second vasopressor in septic shock refractory to norepinephrine

13-261 - Comparison of a multimodal stepwise shivering management strategy to a neuromuscular blocker-first strategy for targeted temperature management after cardiac arrest

10-329 - Comparison of alpha-2a agonists as adjunctive therapy for alcohol withdrawal syndrome

10-364 - Comparison of continuous infusion versus bolus hypertonic saline administration for inducing hypernatremia in the treatment of cerebral edema

12-313 - Comparison of electrolyte abnormalities when a phosphate containing versus a non-phosphate containing renal replacement solution is utilized: a retrospective cohort study

12-013 - Comparison of high-dose versus standard-dose levetiracetam maintenance therapy in adult patients with status epilepticus

12-178 - Comparison of intravenous milrinone therapy versus standard hemodynamic augmentation on the severity and duration of symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage (aSAH)

11-258 - Comparison of midazolam and propofol sedation strategies in survivors of cardiac arrest during targeted temperature management

9-303 - Comparison of the adjunctive use of ketamine versus standard of care in sedation and analgesic management in patients receiving veno-venous extracorporeal membrane oxygenation

12-414 - Comparison of time to shock reversal with hydrocortisone 200 mg/day versus hydrocortisone 300 mg/day in intensive care unit (ICU) patients with septic shock

13-338 - Comparison of vasopressor requirements in mechanically ventilated patients sedated with dexmedetomidine versus propofol

13-218 - Correlation of lipophilic and hydrophilic statins to major bleeding events

10-078 - Cost comparison and utilization of activated prothrombin complex concentrate (aPCC) for anticoagulant-related bleeding

11-269 - Cost effectiveness of argatroban versus heparin anticoagulation in adult extracorporeal membrane oxygenation patients

10-150 - Delays in administration of the second antibiotic dose in severe sepsis and septic shock

9-438 - Description of bivalirudin anticoagulation in pediatric patients with ventricular assist devices

12-168 - Design and implementation of a hospital guideline for the management of calcium channel blocker and beta blocker toxicity

11-385 - Development and implementation of a multidisciplinary education plan for delirium in the intensive care unit

10-010 - Development of a medication therapy management scoring index in critically ill patients at a community hospital

11-363 - Development of a standardized protocol for the use of intravenous vitamin C, thiamine, and hydrocortisone in the treatment of sepsis and septic shock

10-013 - Development of an algorithm for clinical decision making regarding intravenous loop diuretics in patients with acute decompensated heart failure

9-270 - Diabetic ketoacidosis management: a comparison of a two-bag versus a one-bag system in adult patients

12-182 - Diuretic response to furosemide plus albumin vs furosemide alone in surgical intensive care unit patients

11-281 - Drug utilization evaluation comparing the incidence of acute kidney injury in critically ill patients receiving vancomycin and piperacillin/tazobactam versus vancomycin and cefepime or meropenem

10-027 - Effect of a pharmacist-driven medication review on delirium in critically ill patients

11-329 - Effect of adjunct midodrine on length of stay in vasopressor-dependent adult ICU patients

13-398 - Effect of Amitriptyline on Delirium in Trauma Intensive Care Unit (ICU) Patients

13-107 - Effect of cefepime dosage on adverse effects in critically ill adult patients

11-211 - Effect of oral midodrine on duration of intravenous vasopressor therapy and hospital length of stay

13-312 - Effectiveness of adjunctive midodrine therapy for decreasing duration of norepinephrine use in patients admitted to the intensive care unit

13-306 - Effectiveness of protocol for decreasing utilization of pantoprazole in the intensive care unit to avoid unnecessary continuation upon discharge

12-196 - Efficacy and Safety of Push Dose Phenylephrine in Adult ICU Patients

13-054 - Efficacy of a nurse driven diabetic ketoacidosis protocol on diabetic ketoacidosis treatment and serum osmolarity

10-043 - Efficacy of melatonin for the prevention of intensive care unit (ICU) delirium

11-003 - Efficacy of midodrine to decrease intravenous vasopressor requirements in ICU patients

13-061 - Efficacy of using antipsychotics as adjunct therapy to benzodiazepines in severe alcohol withdrawal

13-326 - Enteral naloxone for opioid-induced constipation: a single pediatric intensive care unit experience

13-257 - Enteral nutrition in critically ill patients with concurrent vasopressors: is it safe

13-244 - Evaluating adherence to an institutional insulin infusion protocol for critical care patients in a community healthcare system

9-304 - Evaluating the management of patients recovering from septic shock: a retrospective before and after shock protocol study

12-280 - Evaluating the use of phenobarbital for treatment of severe alcohol withdrawal syndrome in the medical intensive care unit

11-347 - Evaluation and Optimization of an Alcohol Withdrawal Protocol

13-189 - Evaluation of 4-Factor Prothrombin Complex Concentrate (4F-PCC) for reversal of warfarin in a tertiary care hospital

11-125 - Evaluation of 4-factor prothrombin complex concentrate in an era of expanding use

9-015 - Evaluation of a pharmacist driven CAM-ICU assessment protocol

12-395 - Evaluation of a standardized vancomycin administration time protocol on vancomycin levels in medical intensive care unit patients in an academic medical center

12-065 - Evaluation of adherence to daily spontaneous awakening trials (SATs) and spontaneous breathing trials (SBTs) and effect on clinical outcomes: a before-, during-, and after-education study

13-288 - Evaluation of aerosolized epoprostenol sodium utilization in the intensive care unit

13-416 - Evaluation of albumin use in a 48 bed adult intensive care unit

9-099 - Evaluation of alcohol withdrawal management and prescribing practices in the trauma-neuro critical care and medical intensive care units

10-419 - Evaluation of Alteplase Regimen and Outcomes in the Treatment of Pulmonary Embolism

10-336 - Evaluation of an insulin infusion protocol for glycemic control at an academic medical center

11-296 - Evaluation of antipsychotic continuation for intensive care unit (ICU) delirium management through transitions of care

13-242 - Evaluation of antipsychotic therapy for intensive care unit (ICU) delirium

10-361 - Evaluation of antipsychotics known to cause QTc prolongation in adult intensive care unit patients

11-158 - Evaluation of appropriate analgesia and sedation prior to neuromuscular blocking agent initiated in critically ill patients

9-073 - Evaluation of current practices for fentanyl drip titration in ventilated patients admitted to the medical intensive care unit

13-111 - Evaluation of dexmedetomidine use and appropriateness in adult patients admitted to an intensive care unit

10-031 - Evaluation of early administration of insulin glargine in the acute management of diabetic ketoacidosis

13-047 - Evaluation of efficacy of hypertonic saline and mannitol in combination in patients with a traumatic brain injury

11-026 - Evaluation of factors contributing to prolonged intubation times in patients undergoing cardiovascular surgery

11-410 - Evaluation of fluid resuscitation in sepsis

11-064 - Evaluation of Fosphenytoin Therapeutic Drug Monitoring in the Neurocritical Care Unit

11-156 - Evaluation of insulin infusions in critically ill patients

10-360 - Evaluation of ketamine for sedation in the intensive care unit (ICU)

10-443 - Evaluation of medication discrepancies upon discharge from intensive care units at an academic medical center in Riyadh, Saudi Arabia

11-009 - Evaluation of medications used as part of a rapid response team without a pharmacist in a rural health center

11-119 - Evaluation of midazolam utilization and dosing strategy for refractory status epilepticus

13-005 - Evaluation of midodrine use for septic shock in the medical intensive care unit (ICU)

9-209 - Evaluation of pain control in patients with thermal injury

11-155 - Evaluation of phentolamine and hyaluronidase use following extravasation of vasopressors

9-350 - Evaluation of Prescribing Patterns of Quetiapine for Delirium in Critically Ill Patients

9-098 - Evaluation of prescribing practices of hyperosmolar therapy in adult patients with traumatic brain injury

10-239 - Evaluation of prophylactic antibiotics in penetrating brain injuries at an academic Level 1 Trauma Center

9-145 - Evaluation of protocol based, symptom triggered phenobarbital treatment for alcohol withdrawal syndrome in critically ill patients

13-185 - Evaluation of safety and efficacy of rapid-titration treprostinil at a large community hospital

10-040 - Evaluation of Single versus Serial Procalcitonin Lab Monitoring in Critically Ill Patients

12-140 - Evaluation of systemic corticosteroid use in septic shock patients across a multi-hospital health system

9-131 - Evaluation of the appropriateness of prophylactic antibiotics in patients with external ventricular drains

13-212 - Evaluation of the duration of epilepsy prophylaxis in aneurysmal subarachnoid hemorrhage

9-035 - Evaluation of the effect of intravenous acetaminophen on defervescense in critically ill patients

9-387 - Evaluation of the Effects of Midodrine on Vasopressor Weaning in the Intensive Care Units

11-133 - Evaluation of the safety and efficacy of phenobarbital for the management of acute alcohol withdrawal in the intensive care unit

11-056 - Evaluation of the use of oral midodrine to wean vasopressors in critically ill patients diagnosed with shock

11-409 - Evaluation of utilization of a continuous insulin infusion program in critically-ill patients

9-371 - Evaluation of vasopressin response in critically ill patients on chronic ACE-inhibitor therapy

11-154 - Evaluation of vasopressin usage in critical care patients

13-076 - Evaluation of vasopressor discontinuation sequence on hemodynamic stability in septic shock

12-074 - Fentanyl versus hydromorphone infusion for pain and sedation in mechanically ventilated patients in the intensive care unit

12-064 - Fixed Dose Kcentra Protocol for Emergent Warfarin Reversal

9-360 - Fixed dose prothrombin complex concentrate versus variable dosing for the emergent reversal of warfarin in a community hospital

13-068 - Heparin dosing in ECMO patients

9-231 - Hydrocortisone and Fludrocortisone versus Hydrocortisone Alone in Critically Ill Medical Patients with Septic Shock

9-227 - Identifying risk factors for ventilator associated pneumonia due to Pseudomonas aeruginosa in a trauma population

10-189 - Impact of a pharmacist- managed quality improvement initiative on the appropriateness of stress ulcer prophylaxis in critically ill adults

13-100 - Impact of a pharmacist-driven sliding scale insulin protocol on glycemic control in a critical care setting

10-054 - Impact of a standardized trauma admission order set on time to venous thromboembolism prophylaxis in a level I trauma center

9-252 - Impact of an electronic sepsis surveillance tool on early sepsis management in the emergency department

9-271 - Impact of changing from weight-based to standard dosing of continuous intravenous fentanyl infusion on overall fentanyl utilization in a medical-surgical intensive care unit

11-195 - Impact of Chloride Containing Drug Diluents on AKI Incidence in the Surgical Intensive Care Unit

10-193 - Impact of continuous vasopressin infusion in patients diagnosed with shock

11-417 - Impact of daily patient medication reviews in the intensive care unit (ICU)

13-016 - Impact of dexmedetomidine use on hospital length of stay and benzodiazepine requirements in patients being treated for alcohol withdrawal

13-271 - Impact of enteral clonidine on the duration of dexmedetomidine infusions in intensive care unit patients

13-315 - Impact of high-dose intravenous vitamin C for treatment of sepsis on point-of-care blood glucose readings

11-248 - Impact of intravenous N-acetylcysteine in non-acetaminophen acute liver failure in the intensive care unit

13-273 - Impact of moderate hyperchloremia on trauma patients treated with continuous infusion hypertonic saline

11-101 - Impact of pharmacist-led interventions on stress ulcer prophylaxis and atypical antipsychotic use upon discharge from the intensive care unit

12-249 - Impact of pharmacy intervention on inappropriate use of stress ulcer prophylaxis in the intensive care unit (ICU)

11-259 - Impact of phenobarbital in the management of alcohol withdrawal syndrome on outcomes in critically ill adults

10-433 - Impact of procalcitonin on duration of antibiotic therapy in adults with sepsis or septic shock in the intensive care unit

11-210 - Impact of prolonged postoperative dexmedetomidine infusions on analgesic requirements in pediatric patients

13-165 - Impact of protocolized sleep improvement with early mobilization utilizing fitness watch technology in the intensive care unit

12-133 - Impact of steroids in septic shock requiring low dose norepinephrine

13-168 - Implementation of clinical pharmacy services to assess patients with intensive care unit delirium

9-282 - Implementation of ICU bundles and the impact on pain, agitation, and delirium in critically ill patients in the ICU

9-088 - Implementation of pharmacy services into an emergency department

11-072 - Improving adherence to a standardized ventilator order set: a quality improvement project

11-127 - Improving glycemic control in critically ill patients by use of a computerized dosing support system in a community hospital setting

9-030 - Improving the process of alteplase management for inpatient acute ischemic stroke

10-402 - Incidence and risk factors for multidrug resistant infection in trauma patients admitted with penetrating abdominal injuries

12-265 - Incidence of acute kidney injury in septic patients receiving normal saline or balanced fluids

11-306 - Incidence of antibiotic administration before lumbar puncture and CSF gram stain in critically ill patients with suspected bacterial meningitis and the effect on patient outcomes

12-177 - Incidence of fever associated with dexmedetomidine in an adult intensive care unit

9-242 - Individualized versus fixed schedule benzodiazepine therapy for alcohol withdrawal: a comparison of treatment strategies at a university-affiliated acute care teaching hospital

11-070 - Initiation of Pharmacy Consult Services to Improve Sepsis Related Outcomes in a Multi-Hospital Health System

13-366 - Insulin infusion protocol for acute hyperglycemic crisis: assessing compliance, safety, and efficacy in an academic medical center

10-403 - Interventions for hyperglycemia in the medical and surgical intensive care unit

12-203 - Intrapulmonary shunting secondary to intravenous nicardipine in post-operative cardiac surgery patients: a retrospective study

12-076 - Intravenous Lidocaine Infusion for Management of Chronic Pain in the ICU

13-256 - Ketamine for analgosedation in mechanically ventilated patients

11-286 - Managing agitation and sedation in the critically ill: intravenous dexmedetomidine to oral clonidine

12-257 - Medication Use Evaluation of 4-Factor Prothrombin Complex (Kcentra®) at an Urban Academic Medical Center

13-381 - Medication use evaluation of methylene blue

12-351 - Medication use evaluation of milrinone for the treatment of cerebral vasospasm associated with subarachnoid hemorrhage

11-116 - Medication use evaluation of vasopressin and incidence of hypotension in a critical care setting

13-172 - Medication use evaluation: albumin use post-cardiothoracic surgery

10-151 - Midodrine for adjunctive support in the weaning of vasopressor infusions in the intensive care unit

9-094 - Modafinil for wakefulness in the neurocritical care unit

11-212 - Opioid shortage: impact on critically ill patients

12-104 - Opportunities for the transition from dexmedetomidine to enteral clonidine

12-185 - Optimal timing of venous thromboembolism (VTE) prophylaxis initiation in all trauma patients

13-367 - Outcomes of a vasopressin continuous infusion protocol in patients with central diabetes insipidus

12-169 - Outcomes of activated prothrombin complex concentrate in patients using factor-Xa inhibitors and experiencing acute major bleeding

11-324 - Patient outcomes in an adult intensive care unit (ICU) based on depth of sedation while intubated; a retrospective chart review

10-266 - Pharmacist led stress ulcer prophylaxis management in the intensive care unit

11-240 - Pharmacy Facilitated Education of Appropriate Procalcitonin Assays and Physician Response

12-361 - Phenobarbital compared to lorazepam in the treatment of alcohol withdrawal in a community hospital

10-331 - Pilot Analysis of Outcomes Between Monitored Anesthesia Care With Dexmedetomidine and General Anesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement

11-057 - Predicting patient response to dexmedetomidine in mechanically ventilated intensive care unit patients

11-166 - Reduced dose alteplase in the treatment of acute pulmonary embolism

10-271 - Retrospective analysis of pharmacist impact on advanced cardiovascular life support guideline adherence and outcomes during in-hospital cardiac arrest

12-212 - Retrospective analysis of the safety and efficacy of angiotensin II in the treatment of vasodilatory shock within an urban teaching hospital

13-408 - Retrospective study on the use of hydrocortisone plus fludrocortisone in adults with septic shock

12-041 - Rifaximin for the treatment of septic shock in cirrhotic patients

12-225 - Role of single versus dual antiepileptic drug prophylaxis after traumatic brain injury and spontaneous intracerebral hemorrhage

13-283 - Safety and efficacy of hyperosmolar therapy in elevated intracranial pressure

12-116 - Safety of high dose dexmedetomidine in adult intensive care unit patients

11-015 - Safety of ketamine and propofol when used for sedation in mechanical ventilation in a trauma ICU

10-042 - Steroid dosing for chronic obstructive pulmonary disease (COPD) exacerbations in the critically ill

10-197 - Steroid dosing in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in criticially ill adults

12-251 - Target Richmond agitation-sedation score (RASS) achievement with implementation of a multi-component order set for sedation in the intensive care unit

11-406 - Targeted temperature management and patient outcomes after cardiac arrest

11-030 - The opioid sparing effects of ketamine in an adult ICU population

12-372 - The use of propofol plus dexmedetomidine in patients experiencing severe alcohol withdrawal in the intensive care unit

12-295 - The use of vitamin C, hydrocortisone, and thiamine in patients diagnosed with septic shock

10-169 - Treatment bundle of intravenous ascorbic acid, thiamine, and hydrocortisone for patients with sepsis in the intensive care unit

10-198 - Treatment of acute hepatic encephalopathy in the intensive care

10-202 - Treatment of acute hepatic encephalopathy in the intensive care

10-417 - Use of adjunctive ketamine in resistant alcohol withdrawal: impact on symptom severity

12-077 - Use of guanfacine for sedation and agitation in the intensive care unit

11-021 - Utilization of 4-factor prothrombin complex concentrate for reversal of oral factor Xa inhibitor associated acute major bleeding: a case series

10-407 - Utilization of nebulized medications for inhalational lung injury in burn patients

11-159 - Utilization trends of albumin five percent at a community teaching hospital

11-387 - Utilizing a clonidine protocol to assist the weaning of dexmedetomidine infusions

11-420 - Vasopressor utilization in septic shock: an evaluation of initiation and weaning of vasoactive agents at Regional Health Rapid City Hospital

12-379 - Which vasopressor should be stopped first? An accountable care organization multicenter study in septic shock patients with dual vasopressor therapy

11-083 - Y-site compatibility of intravenous levetiracetam with commonly used critical care medications

9-431 - 4-Factor prothrombin complex concentrate (4FPCC) dosing strategies: a retrospective evaluation

13-159 - A Medication Utilization Evaluation for the Appropriateness of Use of Intravenous Chlorothiazide

12-227 - Analysis following implementation of an updated substitution protocol for inhaled medications

13-323 - Analysis of Converting Insulin Detemir to Insulin Glargine: A Medication Use Evaluation

12-259 - Analysis of hypoglycemic events in an inpatient setting: a medication use evaluation

11-447 - Antibiotic prescribing during transitions of care for hospitalized patients diagnosed with pneumonia

12-373 - Antiemetic patterns of use and outcomes in a community teaching hospital

12-308 - Appropriate use of 4-factor prothrombin complex concentrate: a retrospective study

9-220 - Appropriate use of albumin at a tertiary care facility: A medication utilization evaluation

13-392 - Appropriate use of epoetin alfa in the treatment of anemia in hemodialysis and continuous renal replacement therapy patients admitted to a community acute care hospital

10-383 - Appropriate Use of Heparin-Induced Thrombocytopenia Lab Panels